Good news for DEPO regarding the label: Listed incidence of Dizziness and Somnolence far lower than gabapentin. Once-daily, no major restrictions. Very clean. This will definitely be extremely helpful in selling this drug, especially in a market with a lot of generic competition.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.